Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
16
result was found. Results that relate to
Rapid health technology assessment
Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer
Published on
New Medicine
2021,31(1):350-356.
6731 times
2404 times
Shan SHEN
Jie YANG
Yun-Xia LIU
Hai-Ming MA
Ning HOU
Anlotinib
Advanced non-small cell lung cancer
Rapid health technology assessment
Details
Clinical comprehensive evaluation of albumin-bound paclitaxel in the treatment of metastatic pancreatic cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(3):294-304.
1952 times
857 times
Xin-Cai ZHAO
Yao QIU
Wan-Hu ZHU
Rong XU
Cheng GUO
Jian-Ping ZHANG
Albumin-bound paclitaxel
Metastatic pancreatic cancer
Clinical comprehensive evaluation
Rapid health technology assessment
Details
Teriparatide treatment for osteoporosis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):75-84.
782 times
477 times
LYU Peng
ZHANG Jingli
WAN Yuansheng
HUANG Yifei
YOU Ruxu
Teriparatide
Osteogenesis
Safety
Effectiveness
Economy
Rapid health technology assessment
Details
Dapagliflozin in the treatment of chronic heart failure: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(5):554-563.
3284 times
802 times
An-Hua WEI
Lu WANG
Lu ZENG
Xue-Peng GONG
Dong LIU
Dapagliflozin
Chronic heart failure
Effectiveness
Safety
Economy
Rapid health technology assessment
Details
Rapid health technology assessment of dulaglutide for the treatment of type 2 diabetes mellitus
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(8):931-940.
1883 times
561 times
Yuan YAO
Fen-Li SU
Xu SUN
Shi-Yin FENG
Fen XIONG
Qing-Qun CAI
Dulaglutide
Type 2 diabetes mellitus
Rapid health technology assessment
Details
Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1388-1400.
1209 times
477 times
Jian-Cheng ZHOU
Chun-Mei JI
Wen-Tong FANG
Ying ZOU
Yong-Qing WANG
Yuan-Yuan FU
Alirocumab
Hypercholesterolemia
Safety
Efficacy
Cost-effectiveness
Rapid health technology assessment
Details
Dexmedetomidine for sedation in the ICU patients on mechanical ventilation: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(4):441-448.
1088 times
1202 times
LI Wenping
DENG Pingyang
YANG Lin
DU Xian
CAI Jiangxia
Dexmedetomidine
Intensive care unit
Mechanical ventilation
Sedation
Rapid health technology assessment
Details
Argatroban in the treatment of acute ischemic stroke: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(5):549-560.
1283 times
508 times
ZHUANG Zhijiang
ZHANG Qiang
CHEN Zhijia
ZHANG Lihong
Argatroban
Acute ischemic stroke
Rapid health technology assessment
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):778-789.
1211 times
287 times
QIN Fang
WU Kunrong
LIU Chengyu
LIU Daihua
Ertugliflozin
Type 2 diabetes mellitus
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):790-800.
1115 times
243 times
LI Wenyan
PAN Xiding
JIE Qiong
LI Yuanyuan
TANG Mufei
Tislelizumab
Non-small cell lung cancer
First-line treatment
Rapid health technology assessment
Details
Romiplostim for the treatment of primary immune thrombocytopenia in adults: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(8):909-918.
971 times
286 times
LI Jie
XIE Jun
HAN Yi
MENG Ying
GAO Liyuan
SHI Xiaohui
JIANG Zhitao
Romiplostim
Primary immune thrombocytopenia
Efficacy
Safety
Economic
Rapid health technology assessment
Details
CDK4/6 inhibitors in the first-line treatment of HR+/HER2- advanced stage breast cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1017-1029.
893 times
192 times
LI Anna
XIA Zhengzheng
CAI Jiali
LIAN Zhuoshi
MENG Jun
CDK4/6 inhibitors
Endocrine therapy
HR+/HER2- advanced breast cancer
Rapid health technology assessment
Details
Four intravenous iron formulations in the treatment of iron deficiency anemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1030-1043.
877 times
192 times
XING Zhicong
SUN Fudong
XUE Qingxia
ZHANG Bei
MU Shengjun
ZHAO Quan
Iron sucrose
Iron dextran
Ferric carboxymaltose
Iron isomaltoside
Iron deficiency anaemia
Rapid health technology assessment
Details
HLA-B*5801 gene polymorphisms detection in prediction of severe drug eruption associated allopurinol: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1044-1053.
960 times
203 times
CAO Jinjin
LING Ya
ZHANG Jie
ZHANG Jingjing
ZHU Jianguo
CAO Xiufang
Allopurinol
HLA-B*5801 gene testing
Severe drug eruption
Rapid health technology assessment
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1147-1155.
317 times
60 times
YU Fang
ZENG Lu
WEI Anhua
GONG Xuepeng
WANG Lu
Edaravone
Acute ischemic stroke
Efficacy
Safety
Economy
Rapid health technology assessment
Details
1
2
下一页